The Patent Finder

Exelixis, Inc.

91 patents currently held · Updated Nov 15, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 5 name spellings.

22
Ending by 2030
May 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 13 to 25, 2026 · next Dec 13
  • 1 fee due Jan 25, 2027
    The maintenance fee for Compounds for the Treatment of Kinase-Dependent Disorders (US 11,708,367) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
  • 3 fees due Feb 8 to 22, 2027 · next Feb 8
  • 1 fee due Mar 19, 2027
    The maintenance fee for Crystalline Solid Forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, Processes for Making, and Methods of Use (US 11,760,726) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.
  • 1 fee due May 3, 2027
    The maintenance fee for c-Met modulators and methods of use (US 9,174,947) comes due May 3, 2027. Unpaid by Nov 3, 2027, it lapses early.
  • 2 fees due Jun 10 to 17, 2027 · next Jun 10
  • 1 fee due Jul 28, 2027
    The maintenance fee for Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such Compounds (US 10,543,206) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.
  • 1 fee due Aug 4, 2027
    The maintenance fee for C-Met modulator pharmaceutical compositions (US 10,548,888) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
  • 1 fee due Sep 17, 2027
    The maintenance fee for Crystalline Fumarate Salt of (S)-[3,4-Difluoro-2-(2-Fluoro-4-Iodophenylamino)PHENYL] [3-Hydroxy-3-(PIPERIDIN-2-YL) AZETIDIN-1-YL]-METHANONE (US 10,590,102) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
  • 1 fee due Oct 30, 2027
    The maintenance fee for Method of treating cancer (US 11,969,419) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 17, 2026
  • 4 terms have ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,067,436c-Met modulators and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,703,805Modulators of LXR
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,178,532C-Met Modulators and Method of Use
In force
 · Medium confidence
In forceMedium confidence
US 8,642,584Method of using PI3K and MEK modulators
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,989,622Phosphatidylinositol 3-kinase inhibitors and methods of their use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,998,995LXR and FXR modulators
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,999,006Methods of using MEK inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,044,062Substituted pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors of phospatidylinositol 3-kinase alpha
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,012,956Tropane compounds
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,803,839Azetidines as MEK inhibitors for the treatment of proliferative diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 91 patents shown.
Pro members see all 91.
Pro members: see all 91 patents
Also on record, not counted in the 91: 2 patents in force now held by others · 100 lapsed for an unpaid fee · 35 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

12 pending · 35 abandoned · 113 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited